Digital Application-Based Nursing Intervention
Health Outcomes of Digital Application-Based Nursing Intervention in Kidney Transplant Recipients
調査の概要
詳細な説明
This study utilizes a pre-experimental, one-group pretest-posttest design to evaluate how a digital application-based nursing intervention affects operational health outcomes in kidney transplant recipients. The study is conducted at the outpatient clinic of the Assiut Kidney Transplantation Unit, Assiut University Urology Hospital, Egypt. A purposive sample of 50 adult kidney transplant recipients (aged 20-65 years) who underwent transplantation between June 2024 and June 2026 is recruited. The intervention is systematically carried out across three distinct phases:
- Preparatory Phase: Includes initial tool design, expert validation, administrative permissions, and a pilot study on 10% of the sample.
- Implementation Phase: Baseline assessments are conducted using translated standardized tools. Patients and their relatives are then trained on utilizing the "MyTherapy" smartphone application for medication prompts, symptom tracking, and daily logging. Concurrently, patients receive an illustrated educational booklet in simple Arabic covering essential post-transplant care, dietary guidelines, and stress management.
- Evaluation Phase: The longitudinal effects of the digital nursing intervention are evaluated 1 month and 3 months post-intervention.
The operationalized health outcomes and changes from baseline are measured using four validated instruments: a Patient Assessment Questionnaire (assessing patient demographics, preoperative and intraoperative clinical data, and post-operative complications); the Morisky Medication Adherence Scale (MMAS-8) to measure treatment compliance; the Self-Management Scale for Kidney Transplant Recipients (KTR-SMS) to track vital signs monitoring and daily coping; and the Self-Perceived Burden Scale to assess the psychological strain on caregivers. Statistical analysis of the collected data will be performed using IBM SPSS Statistics software.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Martha Helal Roshdy, PhD Cand
- 電話番号:+20102446650
- メール:Marthah@aun.edu.eg
研究場所
-
-
-
Asyut、エジプト、71515
- Assiut University Urology Hospital
-
コンタクト:
- Martha Helal Roshdy, PhD Cand
- 電話番号:+201024465650
- メール:Marthah@aun.edu.eg
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Adult kidney transplant recipients (aged 20-65 years).
- Patients transplanted between June 2024 and June 2026 who are currently maintained on regular outpatient follow-up.
- Patients who have access to a smartphone compatible with the mobile application.
Exclusion Criteria:
- Patients and family members who are illiterate or unable to use the mobile application effectively due to literacy limitations.
- Patients with severe cognitive impairment or psychiatric conditions
- Patients with auditory and visual disorders.
- Patients with failed graft.
- Patients who are lost to follow-up.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Experimental group
Kidney transplant recipients in this single group receive a digital nursing intervention consisting of the MyTherapy mobile application for medication reminders and symptom tracking, accompanied by an illustrated educational booklet in simple Arabic covering essential post-transplant self-care and lifestyle guidelines.
|
A multi-component, digital application-based nursing intervention designed to improve post-transplant health outcomes.
The intervention consists of two main components: 1) The MyTherapy smartphone application, utilized by patients to receive tailored medication reminders, track post-operative symptoms, and maintain daily health logs.
2) A comprehensive, illustrated educational booklet written in simple Arabic to guide patients on essential post-transplant self-care, medication compliance, vital signs self-monitoring, and necessary lifestyle modifications.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Medication Adherence
時間枠:Baseline, 1 month, and 3 months post-intervention
|
Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8).
Total scores range from 0 to 8, where higher scores indicate better adherence levels (high adherence = 8, medium adherence = 6 to <8, low adherence = <6).
|
Baseline, 1 month, and 3 months post-intervention
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Patient Self-Management Behaviors
時間枠:Baseline, 1 month, and 3 months post-intervention
|
Self-management will be evaluated using the Self-Management Scale for Kidney Transplant Recipients (KTR-SMS).
Total scores range from 24 to 96, with higher scores reflecting greater patient self-management capabilities (high = 71-96, moderate = 55-70, low = 24-54).
|
Baseline, 1 month, and 3 months post-intervention
|
|
Change in Self-Perceived Burden
時間枠:Baseline, 1 month, and 3 months post-intervention
|
The extent to which patients feel their care places a strain on caregivers will be measured using the Self-Perceived Burden Scale.
Total scores range from 10 to 50, with higher scores indicating a greater self-perceived burden (high burden = 21-50, low burden = 10-20).
|
Baseline, 1 month, and 3 months post-intervention
|
協力者と研究者
スポンサー
捜査官
- スタディチェア:Magda Ahmed Mohamed, PhD、Faculty of Nursing, Assiut University
- スタディチェア:Rabea Ahmed Gadelkareem, MD、Assiut University
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 1120261453
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。